QAACX
Price
$55.87
Change
-$0.33 (-0.59%)
Updated
Jul 13 closing price
Net Assets
3.82B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

QAACX vs VSTSX

QAACX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
QAACX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QAACX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. QAACX (3.82B). VSTSX pays higher dividends than QAACX: VSTSX (1.07) vs QAACX (0.00). QAACX was incepted earlier than VSTSX: QAACX (23 years) vs VSTSX (10 years). QAACX (1.17) is less costly to investors than VSTSX (0.01). QAACX is a more actively managed with annual turnover of: 62.00 vs. VSTSX (3.00). QAACX has a lower initial minimum investment than VSTSX: QAACX (1500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. QAACX (12.92). VSTSX return over 5 years is better than : 66.56 vs. QAACX (34.64).
QAACXVSTSXQAACX / VSTSX
Total Expense Ratio1.050.0110,500%
Annual Report Gross Expense Ratio1.170.0111,700%
Fund Existence23 years10 years-
Gain YTD8.97811.20580%
Front Load6%N/A-
Min. Initial Investment150050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.82B2.3T0%
Annual Yield % from dividends0.001.070%
Returns for 1 year12.9221.4860%
Returns for 3 years62.1267.0693%
Returns for 5 years34.6466.5652%
Returns for 10 years169.28239.5371%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I